fri12jan4:00 pmfri5:30 pmEMG and NCV Workshop - Part 14:00 pm - 5:30 pm

fri12jan5:00 pmfri7:00 pmNurses Stroke Workshop5:00 pm - 7:00 pm

fri12jan5:00 pmfri7:00 pmStroke Rehabilitation5:00 pm - 7:00 pm

fri12jan5:30 pmfri7:00 pmBotox Workshop5:30 pm - 7:00 pm

fri12jan7:00 pmfri7:10 pmCoffee Break7:00 pm - 7:10 pm

fri12jan7:10 pmfri7:40 pmHow we can harness Rimegepant in clinical practice, today and into the future7:10 pm - 7:40 pm

fri12jan7:40 pmfri8:00 pmMigraine Impact and Improvements in Headache Days, Quality of Life, Disability, and Impact with Eptinezumab7:40 pm - 8:00 pm

fri12jan8:00 pmfri8:20 pmUpdate on Management of Myasthenia Gravis8:00 pm - 8:20 pm

fri12jan8:00 pmfri8:40 pmFocus on timing in Myasthenia Gravis: Case Based Discussion8:00 pm - 8:40 pm

fri12jan8:40 pmfri9:00 pmChampioning patient care in Neuromyelitis optica spectrumdisorder8:40 pm - 9:00 pm

fri12jan9:00 pmGala Dinner9:00 pm

sat13jan8:00 amSESSION 1 - EPILEPSY8:00 am

sat13jan8:00 amsat8:30 amEpileptogenic Zone and Symptomatogenic Networks8:00 am - 8:30 am

sat13jan8:30 amsat8:45 amNew Onset Refractory Status Epilepticus (NORSE)and Febrile infection- related Epilepsy Syndrome ( FIRES)8:30 am - 8:45 am

sat13jan8:45 amsat9:15 amSEEG Methodology8:45 am - 9:15 am

sat13jan9:15 amsat9:35 amNew AEDs9:15 am - 9:35 am

sat13jan9:35 amsat9:50 amEpilepsy Genetics9:35 am - 9:50 am

sat13jan9:50 amsat10:00 amQuestion & Answer Session9:50 am - 10:00 am

sat13jan10:00 amsat10:10 amCoffee Break10:00 am - 10:10 am

sat13jan10:10 amsat10:20 amOFFICIAL OPENING CEREMONY10:10 am - 10:20 am

sat13jan10:20 amSESSION 2 - NEUROLOGY IMMUNOLOGY10:20 am

sat13jan10:20 amsat10:40 amUpdate on Pathophysiology in MS10:20 am - 10:40 am

sat13jan10:40 amsat11:10 pmHow will we be treating multiple sclerosis in 2050?10:40 am - 11:10 pm

sat13jan11:10 amsat11:30 amGuidelines for the treatment of MS11:10 am - 11:30 am

sat13jan11:30 amsat11:50 amBio-marks in MS from Theory to practice11:30 am - 11:50 am

sat13jan11:50 amsat12:00 pmQuestion & Answer Session11:50 am - 12:00 pm

sat13jan12:00 pmsat12:20 pmKey-Simple-To All RMS: KESIMPTA long term data12:00 pm - 12:20 pm

sat13jan12:20 pmsat12:40 pmNew Heights of Efficacy and Convenience with TYSABRI12:20 pm - 12:40 pm

sat13jan12:40 pmsat1:00 pmIf time is brain, it is time for change: Ocrelizumab totality ifevidence12:40 pm - 1:00 pm

sat13jan1:00 pmsat1:20 pmEarly use of MAVENCLAD in the management of MS patients1:00 pm - 1:20 pm

sat13jan1:20 pmsat2:20 pmLunch Break1:20 pm - 2:20 pm

sat13jan2:20 pmSESSION 3 - HEADACHE2:20 pm

sat13jan2:20 pmsat2:40 pmUpdated Research in Headache Therapy, Non CGRP New Targets2:20 pm - 2:40 pm

sat13jan2:40 pmsat3:10 pmApproach to diagnose different types of headache2:40 pm - 3:10 pm

sat13jan3:10 pmsat3:30 pmNon Pharmacological Treatment of Migraine3:10 pm - 3:30 pm

sat13jan3:30 pmsat3:40 pmQuestion & Answer Session3:30 pm - 3:40 pm

sat13jan3:40 pmsat4:10 pmThe only oral CGRP receptor antagonist to treat and prevent migraine – what you need to know3:40 pm - 4:10 pm

sat13jan4:10 pmsat4:30 pmErenumab in Migraine Prevention4:10 pm - 4:30 pm

sat13jan4:30 pmsat4:50 pmLatest Updates in Migraine Management and effective prevention4:30 pm - 4:50 pm

sat13jan4:50 pmsat5:00 pmCoffee Break4:50 pm - 5:00 pm

sat13jan5:00 pmsat6:30 pmEMG and NCV Workshop - Part 25:00 pm - 6:30 pm

sat13jan6:30 pmClosing Remarks6:30 pm

sun14jan9:00 amSESSION 4 - MISCELLANEOUS9:00 am

sun14jan9:00 amsun9:30 amAdvanced Therapy for PD: When to consider9:00 am - 9:30 am

sun14jan9:30 amsun10:00 amNeurophysiology Role, other than EEG and NCS9:30 am - 10:00 am

sun14jan10:00 amsun10:10 amCoffee Break10:00 am - 10:10 am

sun14jan10:10 amsun10:40 amEssential Tremor Approach and Management10:10 am - 10:40 am

sun14jan10:40 amsun11:10 amSurgical Management of Neuropathic Pain10:40 am - 11:10 am

sun14jan11:10 amsun11:30 amQuestion & Answer Session11:10 am - 11:30 am

sun14jan11:30 amsun12:00 pmHow can we better match migraine treatments to our patients’ needs? – Role of Rimegepant11:30 am - 12:00 pm

sun14jan12:00 pmsun12:20 pmTreatment Landscape evolution in Parkinson Disease12:00 pm - 12:20 pm

sun14jan12:20 pmsun12:40 pmToxins injection in Adult Spasticity Management12:20 pm - 12:40 pm

sun14jan12:40 pmsun1:40 pmLunch Break12:40 pm - 1:40 pm

sun14jan1:40 pmSESSION 5 - STROKE1:40 pm

sun14jan1:40 pmsun2:10 pmWake Up Stroke and Extending Thrombolysis Window1:40 pm - 2:10 pm

sun14jan2:10 pmsun2:40 pmMechanical Thrombectomy/Intracranial Stenting2:10 pm - 2:40 pm

sun14jan2:40 pmsun3:00 pmUpdate in ICH Management2:40 pm - 3:00 pm

sun14jan3:00 pmsun3:30 pm2023 Stroke Clinical Trial Updates3:00 pm - 3:30 pm

sun14jan3:30 pmsun3:40 pmQuestion & Answer Session3:30 pm - 3:40 pm

sun14jan3:40 pmClosing Remarks3:40 pm

sun14jan3:40 pmCoffee Break3:40 pm

For more information

© Al Ain Neurology Conference 2024